(Q35173092)

6 August 2017

1 reference

title

Autoreactive T cells in multiple sclerosis (English)

1 reference

6 August 2017

Autoreactive T Cells in Multiple Sclerosis (English)

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

23 November 2023

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

23 November 2023

3

Hafler DA

1 reference

6 August 2017

J. Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1285060

9 September 2022

H. L. Weiner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1285060

9 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1285060

9 September 2022

publication date

1 January 1992

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/08830189209061790

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

International Reviews of Immunology

23 November 2023

published in

1 reference

6 August 2017

9

1 reference

6 August 2017

183-201

1 reference

6 August 2017

3

1 reference

Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth.

6 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Tumor necrosis factor identified in multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Oligoclonal immunoglobulin G in multiple sclerosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Antibodies to Myelin Basic Protein and Measles Virus in Multiple Sclerosis: Precursor Frequency Analysis of the Antibody Producing B Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Multiple sclerosis: updated risks for relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

T-cell receptor V alpha and C alpha alleles associated with multiple and myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

T-cell antigen receptor genes and T-cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

T-cell recognition of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

T cells responsive to myelin basic protein in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

The pathogenesis and therapy of multiple sclerosis is based upon the requirement of a combination of myelin antigens for autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Functional gamma chain-associated T cell receptors on cerebrospinal fluid-derived natural killer-like T cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Decreased autologous mixed lymphocyte reaction in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

MS: a CNS and systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Selective loss of a subset of T helper cells in active multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Interleukin-1 corrects the defective autologous mixed lymphocyte response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Immunotherapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Selection of encephalitogenic rat T-lymphocyte clones recognizing an immunodominant epitope on myelin basic protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Antigen-driven bystander suppression after oral administration of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Multiple sclerosis and molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Identification of the region of T cell receptor β chain that interacts with the self-superantigen MIs-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

In vivo competition between self peptides and foreign antigens in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Astrocytes present myelin basic protein to encephalitogenic T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830189209061790

Viral IgM antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and controls

21 January 2018

9

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

A population-based study of multiple sclerosis in twins

23 November 2023

16

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States

23 November 2023

17

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Histocompatibility determinants in multiple sclerosis, with special reference to clinical course

23 November 2023

18

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients

23 November 2023

36

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis

23 November 2023

37

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Human B cell lines secreting IgM antibody specific for myelin basic protein

23 November 2023

38

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Murine monoclonal anti-myelin basic protein (MBP) antibodies inhibit proliferation and cytotoxicity of MBP-specific human T cell clones

23 November 2023

40

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases

23 November 2023

41

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis

23 November 2023

42

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

HLA-linked and unlinked determinants of multiple sclerosis

23 November 2023

47

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Subtypes of HLA-DQ and -DR defined by DQB1 and DRB1 RFLPs: allele frequencies in the general population and in insulin-dependent diabetes (IDDM) and multiple sclerosis patients

23 November 2023

48

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

An allelic cluster of DQ alpha restriction fragments is associated with multiple sclerosis: evidence that a second haplotype may influence disease susceptibility

23 November 2023

49

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Genomic HLA-typing by RFLP-analysis using DR beta and DQ beta cDNA probes reveals normal DR-DQ linkages in patients with multiple sclerosis

23 November 2023

50

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules

23 November 2023

58

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis

23 November 2023

60

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized

23 November 2023

61

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis

23 November 2023

66

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

T-T cell interactions are mediated by adhesion molecules

23 November 2023

77

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

T-lymphocyte entry into the central nervous system

23 November 2023

79

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis

23 November 2023

82

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Proceedings of the National Academy of Sciences of the United States of America

23 November 2023

88

author name string

Wucherpfennig K. W.

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis

23 November 2023

92

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Decreased autologous mixed lymphocyte reaction in multiple sclerosis

23 November 2023

93

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody

23 November 2023

101

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Loss of suppressor-inducer T-cells in chronic-progressive multiple sclerosis: preliminary results

23 November 2023

103

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Decreased expression of HLA-DR antigens on monocytes in patients with multiple sclerosis

23 November 2023

104

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Monocyte defect causes decreased autoMLR in multiple sclerosis patients

23 November 2023

105

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid

23 November 2023

108

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

23 November 2023

111

1 reference

https://api.crossref.org/works/10.3109/08830189209061790

23 November 2023

Identifiers

1 reference

6 August 2017

1 reference